Suppr超能文献

单盘式莫尔托诺植入物的眼球筋膜囊上放置法

Supra-Tenon's capsule placement of a single-plate Molteno implant.

作者信息

Freedman J, Chamnongvongse P

机构信息

Department of Ophthalmology, SUNY Health Science Center at Downstate, 161 Atlantic Avenue, Brooklyn, NY 11201, USA.

出版信息

Br J Ophthalmol. 2008 May;92(5):669-72. doi: 10.1136/bjo.2007.115121. Epub 2007 Jul 12.

Abstract

AIM

To describe clinical results of a new technique for inserting Molteno implants in a supra-Tenon's capsule location.

DESIGN

Prospective interventional case study.

PARTICIPANTS

19 patients, 18 of whom had suffered previous filter or glaucoma implant failure. Seventeen had open-angle glaucoma, and two had neovascular glaucoma. Seventeen patients were black and two were Asian.

INTERVENTION

All patients underwent supra-Tenon's capsule placement of a single-plate Molteno implant. Goldmann applanation tensions and Snellen visual acuities were determined before the operation and at the last follow-up visit. The numbers of preoperative and postoperative adjunctive drugs were compared before and after surgery.

MAIN OUTCOME MEASURES

Success was defined as intraocular pressure < or = 18 mm Hg with or without anti-glaucoma drugs.

RESULTS

Mean age was 62 years. Mean pressure before and after surgery was 31 and 16 mm Hg, respectively. Mean follow-up was 22 months (range 12-48). Vision returned to within 2 lines of preoperative vision, except in one patient who lost light perception. Surgery was regarded as a failure in four patients, including both patients with neovascular glaucoma. The difference between the median number of drugs used before (three) and after (one) the operation was significant (p<0.001). Complications were minimal, characterised by small choroidal effusions in three patients; all resolved spontaneously.

CONCLUSION

Supra-Tenon's capsule placement of Molteno implants in eyes with previously failed glaucoma surgery is an effective method for controlling intraocular pressure.

摘要

目的

描述一种在眼球筋膜囊上方植入莫尔顿植入物的新技术的临床效果。

设计

前瞻性干预性病例研究。

参与者

19例患者,其中18例曾有过滤过器或青光眼植入物失败史。17例为开角型青光眼,2例为新生血管性青光眼。17例患者为黑人,2例为亚洲人。

干预措施

所有患者均在眼球筋膜囊上方植入单盘莫尔顿植入物。术前及最后一次随访时测定Goldmann压平眼压和Snellen视力。比较手术前后辅助用药的数量。

主要观察指标

成功定义为使用或不使用抗青光眼药物时眼压≤18 mmHg。

结果

平均年龄62岁。手术前后平均眼压分别为31 mmHg和16 mmHg。平均随访22个月(范围12 - 48个月)。除1例患者失去光感外,视力恢复至术前视力的2行以内。4例患者手术失败,包括2例新生血管性青光眼患者。手术前后使用药物中位数(术前3种,术后1种)差异有统计学意义(p<0.001)。并发症极少,3例患者出现少量脉络膜积液;均自行消退。

结论

在既往青光眼手术失败的眼中,在眼球筋膜囊上方植入莫尔顿植入物是控制眼压的有效方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验